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Abstract
Background: The association between CD14-159C/T polymorphism and sepsis has been assessed but results of
current studies appeared conflicting and inconstant. This analysis was aimed to determine whether the CD14-159C/T
polymorphism confers susceptibility to sepsis or is associated with increased risk of death from sepsis.
Method: The authors conducted a comprehensive search of PubMed, EMBASE, ISI Web of Science, Cochrane library,
ScienceDirect, Wiley Online Library and CNKI databases according to a prespecified protocol. Language limits were
restricted to English and Chinese. Two reviewers independently selected the articles and extracted relevant data
onto standardized forms. Disagreements were settled by discussion and suggestions from senior consultants. The
strength of association were evaluated by odds ratio (OR) and 95% confidence interval (CI). Studies failed to fit the
Hardy-Weinberg-Equilibrium were excluded.
Results: The research identified a total of 2317 full-text articles of which 14 articles met the predefined inclusion
criteria. Meta-analysis was performed for allele frequency of C versus T, as well as genotypes CC + CT versus TT
(dominant model), CC versus TT + CT (recessive model), CT versus TT and CC versus TT (additive model). All control
samples were in Hardy-Weinberg proportion. No significant association between CD14-159C/T polymorphism and
sepsis susceptibility or mortality were detected in the overall population. Nonetheless, subgroup analysis of Asian
ethnicity revealed significant association between the CD14-159C/T polymorphism and susceptibility to sepsis in
additive model (CC versus TT: OR = 0.52, 95% CI 0.29–0.92, p = 0.03) and recessive model (CC versus CT + TT: OR = 0.50,
95% CI 0.30–0.84, p = 0.009). Of note, three out of the five papers included in the subgroup focused exclusively on
burn ICU patients.
Conclusions: This meta-analysis demonstrated that CD14-159C/T polymorphism is likely to be associated with
susceptibility to sepsis in Asian population, especially for the TT genotype. However, bias may rise for etiologic
reasons because the majority of subjects in the subgroup came from burn ICU. CD14-159C/T polymorphism is
not relevant to sepsis mortality in any genetic models, regardless of the ethnicities. Due to the exploratory nature
of the study, no adjustment for multiple testing was adopted, and therefore the results should be interpreted
with precaution. Well-designed studies with larger sample size and more ethnic groups are required to further
validate the results.
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Background
Sepsis, a complex clinical syndrome due to a systemic
inflammatory response to bacteria and/or bacterial prod-
ucts, is imposing a huge burden on modern health care
systems [1, 2]. Individual response to sepsis is determined
by many factors, including the virulence of the organism
and the patient’s coexisting conditions [3].
With the sequencing of human genome and the recog-
nition of the degrees of genetic variation, it has become
clear that an individual’s genetic makeup is likely to
have impact on the incidence as well as outcome of
sepsis [4, 5]. As is witnessed by the recent decades, an
explosion of research occurred to address the effect of
genetic predisposition on the development and course
of sepsis, and a single nucleotide polymorphism (SNP)
in CD14 with a frequency higher than 1% in the popu-
lation succeeded to draw global attention [6].
CD14 plays a crucial role in sepsis. CD14 is involved
in LPS recognition and mediates the activation of mono-
cytes/macrophages in gram-negative bacterial infection. In
addition, it is also claimed that LPS is associated even with
the deterioration of gram-positive bacterial infection be-
cause products from such bacteria induce hypersensitivity
to LPS [7]. Additionally, animal study demonstrated that
expression of CD14 interacted with mortality of mice
treated with endotoxin [8]. CD14-159C/T (rs2569190) is a
functional polymorphism located in the 5′UTR of the pro-
moter region of CD14 gene, counting from the transcrip-
tion start site, with a potential role of decreasing or
increasing gene expression in process of sepsis [9]. Thus,
it is necessary to identify whether the genetic heterogen-
eity in CD14 influences the response to bacterial infection.
Several studies tried to establish an association between
CD14 polymorphism and sepsis [10, 11]. However, varied
conclusions have been obtained in different studies. Our
purpose in the current work is to determine whether this
variant in CD14 is associated with an increased risk of
sepsis or higher sepsis-related mortality by means of a
human genome epidemiology review including a meta-
analysis of previous data.
Methods
Literature search strategy
This meta-analysis was performed according to the rec-
ommendations of the Meta-analysis of Observational
Studies in Epidemiology (MOOSE) guidelines [12]. Two
independent investigators performed a systematic review
of English-language and Chinese-language literature in
PubMed, EMBASE, ISI Web of Science, Cochrane li-
brary, ScienceDirect, Wiley Online Library and CNKI
databases with the following terms: (CD14 OR CD14-
159 OR CD14-159C/T OR rs2569190) AND (sepsis OR
septic shock OR severe sepsis OR severe burn OR major
trauma). In addition, we also searched the references of
original research reports and review articles (last search:
2016.09.22). By using the MEDLINE option ‘related arti-
cles’, we tried to find all studies potentially relevant. Both
investigators have received training in literature search,
statistic and evidence-based medicine in Nanjing Univer-
sity. References of the selected publications were manually
scanned to identify other relevant studies.
Inclusion and exclusion criteria
Studies were included in our meta-analysis if 1) they
were focused on the relationship between CD14-159C/T
polymorphism and the susceptibility to sepsis or sepsis-
related mortality, 2) they studied humans, 3) enough
data of selected SNP of both patients and control groups
were clearly stated to calculate odds ratio (OR) and 95%
confidence interval (CI), 4) the genotype frequency of
control group was in accordance with Hardy-Weinberg
equilibrium (HWE) [13]. Sepsis-related mortality was
defined as death caused by sepsis, severe sepsis or sep-
tic shock. For each study, HWE was evaluated using
the goodness-of-fit chi-square test by our investigators.
A p < 0.05 was considered representative of a departure
from HWE.
Exclusion criteria were 1) editorials, letters, comments,
practice guidelines, consensus development conferences,
and book chapters 2) causes of the systemic inflam-
matory response syndrome (SIRS) were not reliably
defined;3) duplications. Disagreements on including/
excluding studies were resolved by consensus. For
studies without full text or sufficient data, we con-
tacted the corresponding authors for additional infor-
mation by e-mail. If no reply or the author refused to
provide the data required in this meta-analysis, the
study was excluded.
Data extraction
Using a standardized form, two investigators independ-
ently extracted data from the included studies. For each
eligible study, the following characteristics were col-
lected: authors, publication date, ethnicity, numbers of
cases, sample size, allele and genotype frequencies. The
frequencies of alleles were calculated for cases and con-
trols from the corresponding genotype distributions.
Both of the investigators checked the extracting data
results and disagreements were settled by discussion.
Senior investigators were invited to discuss if disagree-
ment still existed.
Statistical analysis
We recorded data from all publications with a comput-
erized spreadsheet (Microsoft Excel). ORs and 95% CIs
were calculated to estimate the association between
CD14-159C/T polymorphism and susceptibility or mor-
tality of sepsis. Pooled ORs were calculated for allele
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frequency comparison (C versus T), additive model (CT
versus TT, CC versus TT), dominant model (CC + CT
versus TT), and recessive model (CC versus TT + CT),
respectively. Since the studies included are not as high-
quality as RCTs, random effects models were used in
each analysis whether or not heterogeneity exists. There-
fore the result will be more conservative and can be
interpreted in a homogenous way. The significance of
pooled ORs was determined by Z-test and p < 0.05 was
considered as statistically significant. Due to the explora-
tory nature of the study, p-values were not adjusted for
multiple testing.
Statistical heterogeneity among the studies was
checked by chi-square-based Q-test. An I2 value less
than 50% indicated no significant heterogeneity. Meta-
regression was adopted to determine the potential
source of heterogeneity.
Sensitivity analysis was carried out by omitting one
single study each time to examine the influence of indi-
vidual data sets on the pooled ORs. Publication bias of
literature was assessed using funnel plots and Egger’s
test. An asymmetric plot suggested a possible publica-
tion bias and P value of Egger’s test less than 0.05 was
considered statistically significant. All analyses were per-
formed using the software program RevMan Analyses
software (RevMan 5.0.17) from the Cochrane collabor-
ation. All statistical analyses were performed with Stata
12.0 software (StataCorp, College Station, TX, USA).
The statistical methodology was approved by principal
investigator (Ren, J) and the statistical analysis were per-
formed by trained investigators (Wu, Q and Xu, X).
Results
Characteristics of the studies
The literature search identified a total of 2317 poten-
tially relevant studies in PubMed, EMBASE, ISI Web of
Science, Cochrane Central Register of Controlled Trials,
ScienceDirect, Wiley Online Library and CNKI data-
bases. As was shown in Fig. 1, 552 duplicate records
were removed. Four hundred thirty-nine papers were
also excluded as posters or orals, as well as 222 records
obtained from books. Additionally, 109 studies con-
ducted in animal models were dropped. Nine hundred
seventeen records were analyzed by reviewing the ab-
stracts. After reading abstracts, irrelevant studies were
excluded whereas two additional papers were included
manually after reading reviews. Therefore, a total of 33
papers met the primary inclusion criteria, among which
21 papers failed to provide sufficient data for calcula-
tion of OR and 95% CI and were excluded, as well as
one paper [14] which deviated from HWE in controls.
A total of 14 studies for the association between CD14
polymorphism and sepsis were included in the final
meta-analysis.
Characteristics of included studies were summarized
in Table 1. Ten studies that evaluated the effect of the
CD14 polymorphisms on incidence of sepsis were ultim-
ately analyzed in our meta-analysis, as well as nine studies
that demonstrated the effect of the CD14 polymorphisms
on sepsis-related mortality.
All studies were published in English except for three
in Chinese. Nine studies were performed in Caucasian
populations and five in Asian. In the studies included,
sepsis was commonly defined according to the American
College of Chest Physicians/Society of Critical Care
Medicine guidelines [15].
Test of heterogeneity
Heterogeneity between studies in each comparison was
shown in Table 4 for susceptibility and Table 5 for mor-
tality. Heterogeneity was insignificant (I2 less than 50%)
in the pooled analyses of susceptibility (Table 4), whereas
remarked heterogeneity existed in the evaluation of
mortality in all five genetic models (Table 5). In order
to evaluate the influence of the individual data set to
the overall heterogeneity, every single study was omit-
ted each time in every genetic model. As a result, the
study by Fallavena et al. [16] is the major contributor to
the total heterogeneity (Additional file 1: Tables S1 and
S2). Meta-regression was conducted to determine the
potential source of heterogeneity (Additional file 1:
Table S3), and ethnicity contributes to indispensable
parts of variance.
Fig. 1 Flow chart of study identification and exclusion for
the meta-analysis
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Subgroup analysis was conducted and all the subjects
were stratified by ethnicity. Heterogeneity among studies
in each subgroup was estimated in the five genetic
models. No heterogeneity was observed in each com-
parison in Asian population; on the contrary, evident
heterogeneity remained among Caucasian subgroup
(Tables 4 and 5).
CD14 polymorphism and susceptibility to sepsis
Ten studies reported results on susceptibility to sepsis
(Table 2). The association between the CD14-159C/T
polymorphism and susceptibility to sepsis was analyzed
in these independent studies with 788 cases and 730
controls (Table 4). One hundred ninety-seven of 405
(48.64%) patients with the CD14-159 CC genotype
group developed sepsis, as compared to 198 of 383
(51.69%) of those with CD14-159 TT genotype.
No association between the CD14-159C/T poly-
morphism and susceptibility to sepsis was identified in
any genetic modes (Table 4). However, subgroup meta-
analyses indicated significant association between the
CD14-159C/T polymorphism and susceptibility to sep-
sis in additive model and recessive model (CC versus
TT: OR = 0.53, 95% CI 0.29–0.95, p = 0.03; CC versus
Table 1 Characteristics of studies included in the meta-analysis








Barber, 2007 [28] Caucasian PCR Burn ICU 233 Yes No No Yes
Bronkhorst, 2013 [33] Caucasian High-resolution Melting Analysis Trauma center 219 Yes Yes Yes No
D’Avila, 2006 [30] Caucasian PCR-RFLP General ICU 85 Yes Yes Yes Yes
Dong, 2009 [34] Asian PCR-RFLP Burn ICU 77 Yes Yes Yes No
Dong, 2010 [35] Asian PCR-RFLP Burn ICU 35 Yes Yes Yes Yes
Fallavena, 2009 [16] Caucasian Sequence Analysis ICU 514 Yes Yes Yes Yes
Gibot, 2002 [22] Caucasian PCR-RFLP ICU 212 Yes Yes Yes Yes
Gu, 2008 [29] Asian PCR-RFLP Trauma center 105 Yes Yes Yes No
Heesen, 2002 [25] Caucasian Fluorescence-labeled
Hybridization Probes
Trauma center 58 Yes Yes Yes No
Hubacek, 2000 [26] Caucasian PCR ICU 204 Yes No No Yes
Jessen, 2007 [39] Caucasian PCR-RFLP ICU 452 Yes Yes No Yes
Lin, 2004 [32] Asian PCR-RFLP Burn ICU 16 Yes Yes Yes Yes
Nakada, 2005 [40] Asian PCR-RFLP Surgical ICU 197 Yes Yes Yes No
Shimada, 2011 [41] Asian Fluorescence-labeled
Hybridization probes
ICU 224 Yes Yes No Yes
aHardy-Weinberg equilibrium (HWE) was evaluated using the goodness-of-fit chi-square test. P values were presented. P > 0.05 was considered representative of a
departure from HWE
Table 2 Characteristics of included studies in the meta-analysis analyzing the effect of the CD14 polymorphism on incidence
of sepsis
Study SNP Sepsis Group (n) Control Group (n) Distribution of alleles
CC CT TT CC CT TT Sepsis Group Control Group
C T C T
Bronkhorst, 2013 [33] CD14-159C/T 22 37 20 37 68 35 81 77 142 138
Dong, 2009 [34] CD14-159C/T 3 38 15 4 11 6 44 68 19 23
Dong, 2010 [35] CD14-159C/T 3 9 7 4 7 5 15 23 15 17
Gibot, 2002 [22] CD14-159C/T 19 43 28 44 52 26 81 99 140 104
Gu, 2008 [29] CD14-159C/T 5 23 14 16 35 12 33 51 67 59
Lin, 2004 [32] CD14-159C/T 0 4 3 2 6 1 4 10 10 8
Nakada, 2005 [40] CD14-159C/T 15 43 28 27 42 42 73 99 96 126
D’Avila, 2006 [30] CD14-159C/T 17 19 16 10 16 7 53 51 36 30
Fallavena, 2009 [16] CD14-159C/T 108 172 63 49 78 44 388 298 176 166
Heesen, 2002 [25] CD14-159C/T 5 5 4 15 22 7 15 13 52 36
SNP single nucleotide polymorphism
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CT + TT: OR = 0.50, 95% CI 0.30–0.85, p = 0.010). No
significant association was found in other genetic
models in Asian population and in Caucasian popula-
tion (Fig. 2). Among patients from burn ICU, associ-
ation was found in recessive model (CC versus CT +
TT: OR = 0.34, 95% CI 0.11–1.00, p = 0.05), and board-
line significant association was also observed in addi-
tive model (CC versus TT: OR = 0.33, 95% CI 0.10–
1.11, p = 0.07) (Fig. 3).
CD14 polymorphism and sepsis-related mortality
Nine studies contributed to our analysis of sepsis-related
mortality (Table 3). One hundred forty-five of 456
(31.80%) patients with CD14-159 CC genotype died
from sepsis-related diseases, compared with 257 (32.89%)
patients with CD14-159 CT genotype and 98 (26.70%)
patients with CD14-159 TT genotype.
Figure 3 shows the meta-analysis of the association
between the CD14-159C/T polymorphism and sepsis-
related mortality in an allele frequency comparison.
No association between CD14-159C/T polymorphism
and sepsis-related mortality was identified in any gen-
etic model. No further associations were observed
among burn ICU subgroup. (Table 5) However, an ob-
vious association was found between sepsis-related
mortality and CD14-159C/T polymorphism in Asian
subgroup in allele frequency, additive model and dom-
inant model (C versus T: OR = 0.53, 95% CI 0.31–0.92,
p = 0.02; CC versus TT: OR = 0.40, 95% CI 0.14–1.11,
p = 0.08; TC versus TT : OR = 0.31, 95% CI 0.13–0.76,
p = 0.009; CC + CT versus TT: OR = 0.34, 95% CI 0.16–
0.74, p = 0.007), In Caucasian populations, association
was identified only in TC versus TT (OR = 1.67, 95%
CI .08–2.59, p = 0.02) (Fig. 4).
Publication bias
Funnel plot and Egger’s test were performed to assess
the publication bias of the studies and the results were
shown in Tables 4 and 5. Significant publication bias was
observed in the total data set in the pooled analysis of
the association between CD14-159C/T polymorphism
and susceptibility or mortality. After stratification by
ethnicities, the bias remained remarkable in Caucasian
population but disappeared in the subgroup of Asian
population.
Sensitivity analysis
To examine the influence of the individual data set to
the pooled ORs, every single study involved in this
meta-analysis was omitted each time in every genetic
model. For CD14-159C/T susceptibility to sepsis, after
the exclusion of the study from Fallavena et al. [16], the
pooled results in the following models became signifi-
cant (Fig. 5): C versus T: OR = 0.79, 95% CI 0.66–0.94,
p = 0.01; CC versus TT: OR = 0.60, 95% CI 0.42–0.86,
p = 0.005; CC + CT versus TT: OR = 0.68, 95% CI 0.50–
0.91 p = 0.01. Of note, this study contributed most
remarkably to the heterogeneity of the pooled results fo-
cusing on susceptibility (Additional file 1: Table S1). No
individual study affected the pooled OR in the analysis
of mortality and in each subgroup studies.
Discussion
Sepsis is a complex syndrome initiated by infection and
is characterized by a systemic inflammatory response
[17]. The preponderance of research in sepsis has
focused on dissecting roles of the immune cells, innate
immune regulation, cytokines, and coagulation factors
in response to varying infectious and inflammatory
Fig. 2 Forest plots of association between the CD14-159C/T polymorphism and susceptibility to sepsis in CC vs TT (a) and CC vs CT + TT (b)
genetic models. Significant association was detected in Asian subgroups in these two models. Odds ratios (OR) with 95% confidence intervals
(CI) for individual studies and the pooled OR and 95% CI were given
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mediators [11, 18]. This meta-analysis mainly focused on
the associations between CD14-159C/T polymorphism
and susceptibility to sepsis or sepsis-related mortality.
CD14 is a major component involved in the LPS re-
ceptor complex along with toll-like receptor 4, acting
as a key factor in immune cell recognitions [19]. The
soluble form of CD14 is essential for TLR2 or TLR4
responses in monocytes, macrophages, neutrophils, and
hepatocytes [19–21]. Increased serum CD14 levels have
been shown to correlate with shock and greater mortal-
ity in patients with gram-positive and gram-negative
bacterial infections [22]. Polymorphisms of CD14 have
been widely studied in inflammatory bowel disease and
results showed a varied susceptibility in different popula-
tions, indicating that genotype frequencies vary between
the populations [23, 24].
CD14-159C/T has been identified to correlate with
CD14 serum levels [25–27]. A mass of studies reported
the associations between CD14 SNP and incidence of
sepsis, or sepsis-related mortality [10, 28]. However con-
clusions from different studies are controversial [29, 30].
Thus, in the present study, we identified 15 genetic asso-
ciation studies and used meta-analysis with the genetic
model to evaluate the association of CD14-159C/T poly-
morphism with sepsis.
On one hand, the study investigated relations between
CD14-159C/T polymorphism and susceptibility to sep-
sis. In the total data set, the pooled analysis exhibited no
significant association between the polymorphism and
susceptibility. However, in the pooled analysis focusing
on susceptibility, after omitting the most significant con-
tributor of heterogeneity [16], the results suggested that
Fig. 3 Forest plots of association between the CD14-159C/T polymorphism and susceptibility to sepsis in burn ICU sub group in CC vs TT (a)
and CC vs CT + TT (b) genetic models. Significant association was detected in Asian subgroups in these two models. Odds ratios (OR) with
95% confidence intervals (CI) for individual studies and the pooled OR and 95% CI were given
Table 3 Characteristics of included studies in the meta-analysis analyzing the effect of the CD14 polymorphism on sepsis-related
mortality
Study SNP Non-survivors (n) Survivors (n) Distribution of alleles
CC CT TT CC CT TT Non-survivors Survivors
C T C T
Barber, 2007 [28] CD14-159C/T 19 18 4 51 95 46 56 26 197 187
Dong, 2010 [35] CD14-159C/T 1 4 4 6 12 8 6 12 24 28
Gibot, 2002 [22] CD14-159C/T 5 25 20 14 18 8 35 65 46 34
Hubacek, 2000 [26] CD14-159C/T 21 59 17 32 52 23 101 93 116 98
Jessen, 2007 [39] CD14-159C/T 18 33 11 74 123 55 69 55 271 233
Lin, 2004 [32] CD14-159C/T 0 4 3 2 6 1 4 10 10 8
Shimada, 2011 [41] CD14-159C/T 5 5 11 24 52 26 15 27 100 104
D’Avila, 2006 [30] CD14-159C/T 17 24 9 10 11 14 58 42 31 39
Fallavena, 2009 [16] CD14-159C/T 59 85 19 98 165 88 203 123 361 341
SNP single nucleotide polymorphism
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T allele and TT in additive model (CC versus TT) and
dominant model (CC + CT versus TT) tend to be associ-
ated with increased susceptibility. Subgroup analysis
among Asian population illustrated that the T allele and
the CD14-159 TT genotype was related to susceptibility
to sepsis. Results from sensitivity analysis confirmed this
conclusion, and test of heterogeneity in this subgroup
indicated a high constancy, indicating the steadiness of
the finding. Studies verified that carriage of the T allele
is associated with an increased risk for developing severe
sepsis after major trauma and severe burns [31, 32]. The
potential explanation for this is that the CD14-159 TT
genotype reduces the promoter activity of CD14, result-
ing in decreased TLR2/4 downstream signaling [33].
However, interpretation of this result should be taken
with precaution since the sample size of the Asian sub-
group was relatively small, involving only 654 subjects,
and the strength of this finding was therefore attenuated.
On the other hand, the study evaluated the associations
between CD14 polymorphism and sepsis-related mor-
tality. As our study revealed, CD14 polymorphism was
proved irrelevant to sepsis-related mortality in total
population. Although data among Asian population
reached statistical significance, the significance disap-
peared in subsequent sensitive analysis upon the re-
moval of the study by Shimada et al., which counted for
the largest sample size, indicating that the significance
was derived from bias rather than the accumulative ef-
fects of every study in the subgroup.
The study by Zhang et al. found, that the CD14-159C/
T polymorphism may not be a significant susceptibility
factor in the risk of sepsis and mortality. Furthermore,
only weak associations were observed in Asian popula-
tions and septic shock patients, which is similar with our
conclusion [10]. Although both of us concentrated on
the same topic, we still have some significant differences.
First of all, different studies were included in the current
analysis. In our manuscript, we included 15 papers while
17 papers were included in Zhang’s paper. In Zhang’s
paper, the latest research was done in June 2012 whereas
our study retrieved publications till up to September
2016 and the latest include d article was published in
Fig. 4 Forest plots of associations between CD14-159 polymorphism and sepsis-related mortality in allele frequency (a), additive model (b and c)
and dominant model (d). Odds ratios (OR) with 95% confidence intervals (CI) for individual studies and the pooled OR and 95% CI were given
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2013. In addition, we excluded the paper that did not fit
for the Hardy-Weinberg equilibrium while two reports
deviated from HWE were finally included in the 17 pa-
pers in Zhang’s paper [10]. Secondly, in Zhang’s paper,
they used three out of five genetic models to evaluate
the association while in our manuscript we used all
five genetic models. Thus, our study adds relevant in-
formation to the influence of this genetic variant on
the outcome of sepsis. Finally, comparing the reports
included in Zhang’s paper and our study, the current
study included five additional papers in which four
were conducted in burn ICU [28, 32, 34, 35]. This dif-
ference may lead to the discrepancy in our results.
Therefore a subgroup analysis regarding to burn ICU
was conducted. As a result, marginal difference was
observed in additive model and recessive model. Burn
ICU has several features, including disordered system-
atic immunological function, increased vulnerability to
wound infection [36] and altered metabolic response
[37]. These features may interact with the underlying
mechanism in the pathogenesis of sepsis in general
ICU and Burn ICU. Therefore our result may be more
suitable in burn patients. However, a comprehensive
understanding of the mechanism still calls for further
clinical, preclinical and basic scientific studies.
Still there are several limitations in the present study.
First and foremost comes the small sample size and lack
of patient-level details of some studies included in the
meta-analysis. Genetic association studies, as a branch of
etiology, are undoubtedly an innovative strategy to
explore the latent cause of certain diseases. Yet despite
the rapid advance in the recent decades, when compared
to classical observational epidemiologic studies, genetic
association studies are still relatively rare and the sample
size are generally small, which may partially attribute to
a relatively higher requirement of technicians and facil-
ities. In the case of our analysis, studies reporting blind
genotyping and adjustment for confounders were few. In
addition, we excluded papers whose genotype deviated
from Hardy-Weinberg equilibrium and statistically




95% CI P Chi-
square
p# I2 P* Statistical
PowerLower Upper
CD14-159C/T
C vs T 0.85 0.69 1.05 0.13 14.72 0.10 39% 0.048 0.155
CC vs TT 0.69 0.44 1.08 0.10 15.77 0.07 43% 0.022 0.134
TC vs TT 0.99 0.73 1.35 0.96 11.19 0.26 20% 0.024 0.102
CC + CT vs TT 0.88 0.64 1.22 0.44 13.57 0.14 34% 0.024 0.434
CC vs CT + TT 0.77 0.56 1.05 0.10 12.18 0.20 26% 0.008 0.337
CD14-159C/T in Asian population
C vs T 0.77 0.58 1.02 0.07 3.70 0.45 0% 0.181 0.520
CC vs TT 0.53 0.29 0.95 0.03 3.76 0.44 0% 0.110 0.701
TC vs TT 1.03 0.62 1.73 0.90 4.68 0.32 14% 0.236 0.092
CC + CT vs TT 0.84 0.50 1.42 0.52 5.07 0.28 21% 0.203 0.071
CC vs CT + TT 0.50 0.30 0.85 0.01 1.89 0.76 0% 0.134 0.884
CD14-260C/T in Caucasian population
C vs T 0.91 0.68 1.23 0.55 9.12 0.06 56% 0.387 0.050
CC vs TT 0.84 0.48 1.50 0.56 8.96 0.06 55% 0.32 0.050
TC vs TT 0.93 0.60 1.44 0.75 6.50 0.16 38% 0.035 0.067
CC + CT vs TT 0.88 0.55 1.40 0.59 8.33 0.08 52% 0.276 0.451
CC vs CT + TT 0.92 0.64 1.33 0.66 5.84 0.21 32% 0.800 0.060
CD14-159C/T in Burn ICU
C vs T 0.69 0.40 1.17 0.17 1.17 0.56 0% 0.218 0.290
CC vs TT 0.33 0.10 1.11 0.07 0.81 0.67 0% 0.386 0.517
TC vs TT 0.98 0.41 2.35 0.97 1.61 0.45 0% 0.023 0.050
CC + CT vs TT 0.80 0.35 1.83 0.60 1.75 0.42 0% 0.023 0.082
CC vs CT + TT 0.34 0.11 1.00 0.05 0.63 0.73 0% 0.786 0.435
p#: P-value for heterogeneity test. p*: P-value for Egger’s test; OR odds ratio, CI confidence interval
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assessing publication bias. Second, this study focused
only on the CD14 polymorphism regardless of the likeli-
hood that other genetic variations may also influence
sepsis risk and mortality [38]. Besides, diverse study
populations were included in our study, and different
treatment for sepsis was used in different studies, thus
contributing to differences in patients’ outcome from
sepsis. Many studies had potential biases that influenced
the patient prognosis. A number of papers selected in-
volved burn and trauma patients [28, 34]. Although sub-
group analysis was employed in this study to minimize
the bias derived from ethnicity, and the heterogeneity in
the Asian subgroup seemed statistically insignificant, in-
terpretation of the results from the total and Caucasian




95% CI P Chi-
square
p# I2 P* Statistical
PowerLower Upper
CD14-159C/T
Cvs T 0.97 0.68 1.40 0.88 32.94 <0.01 76% 0.164 0.314
CC vs TT 1.02 0.50 2.10 0.96 29.56 <0.01 73% 0.060 0.363
TC vs TT 1.17 0.67 2.03 0.59 21.97 <0.01 64% 0.877 0.520
CC + CT vs TT 1.08 0.59 1.97 0.79 29.44 <0.01 73% 0.695 0.525
CC vs CT + TT 0.96 0.61 1.50 0.84 20.01 0.01 60% <0.01 0.074
CD14-159C/T in Asian population
C vs T 0.53 0.31 0.92 0.02 0.53 0.77 0% 0.432 0.650
CC vs TT 0.40 0.14 1.11 0.08 0.85 0.65 0% 0.229 0.513
TC vs TT 0.31 0.13 0.74 0.009 1.17 0.56 0% 0.849 0.688
CC + CT vs TT 0.34 0.16 0.74 0.007 0.71 0.70 0% 0.873 0.739
CC vs CT + TT 0.75 0.29 1.95 0.56 1.22 0.54 0% 0.005 0.163
CD14-159C/T in Caucasian population
C vs T 1.16 0.79 1.71 0.46 24.04 <0.01 79% 0.498 0.541
CC vs TT 1.37 0.62 3.04 0.44 22.36 <0.01 78% 0.392 0.631
TC vs TT 1.67 1.08 2.59 0.02 8.17 <0.01 39% 0.648 0.823
CC + CT vs TT 1.56 0.89 2.74 0.12 15.08 <0.01 67% 0.627 0.836
CC vs CT + TT 1.00 0.59 1.69 0.99 18.07 <0.01 72% 0.289 0.085
CD14-159C/T in Burn ICU
C vs T 0.84 0.26 2.73 0.77 8.27 0.02 76% 0.027 0.268
CC vs TT 0.74 0.07 8.30 0.81 6.74 0.03 70% 0.076 0.244
TC vs TT 0.99 0.30 3.30 0.98 0.21 0.90 37% 0.134 0.065
CC + CT vs TT 0.86 0.17 4.27 0.85 5.78 0.06 65% 0.206 0.126
CC vs CT + TT 0.96 0.20 4.67 0.96 4.12 0.13 51% 0.038 0.265
p#: P-value for heterogeneity test. p*: P-value for Egger’s test; OR odds ratio; CI confidence interval
Fig. 5 Sensitive analysis of the pooled analysis of the association of the CD14-159C/T polymorphism with susceptibility to sepsis. Odds ratios (OR)
with 95% confidence intervals (CI) after omitting each individual study were given in C vs T (a), CC vs TT (b), CC + CT vs TT (c)
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populations still calls for precaution. Thirdly, the current
study is an exploratory study without correction for
multiple testing. The study is aimed to generate a hy-
pothesis by means of meta-analysis rather than to test or
confirm it. The aim of our meta-analysis was to generate
a hypothesis rather than to test or confirm it. In this
setting, multiple testing is not preferred. Therefore, our
findings should be interpreted with precaution. Finally
both community-acquired and nosocomial sepsis were
included resulting in a heterogeneity.
Conclusions
In conclusion, the present study revealed a potential asso-
ciation between CD14-159C/T polymorphism and suscep-
tibility to sepsis in the Asian population, especially the
CD14-159 TT genotype. However, due to the exploratory
nature of the current study, our findings should be inter-
preted with precaution. Establishment of a definite associ-
ation between sepsis and CD14 polymorphisms requires
further trials with larger patient numbers and optimized
methodology. Future trials that examine the effect of other
polymorphisms are also needed to consider the effect of
multiple polymorphisms.
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